-->

Myocardial Infarction

Introduction

Myocardial infarction, in layman's terms, Heart Attack, is defined as the myocardial cell death due to prolonged myocardial ischemia. It is caused by partial or complete cessation of blood flow to a part of the myocardium.

The coronary arteries are those that supply blood to the heart/ myocardium. Any occlusion to the coronary artery can cause decreased/ absence of blood flow to that particular part of the myocardium causing oxygen deprivation leading to myocardial ischemia and necrosis. 

Myocardial Infarction

Blood supply to the heart

The heart gets its blood circulation during ventricular diastole

The Coronary arteries originating from the base of the aorta, supply the heart. It is divided into left and right coronary arteries.

  • The left coronary artery further divides into the circumflex artery and the anterior interventricular artery (left anterior descending artery).

  • The right coronary artery further divides into conus arteries(2), posterior interventricular artery (posterior descending artery) and right posterolateral artery.

Myocardial Infarction

Etiology

The modifiable risk factors include smoking, abnormal apolipoprotein ratio, hypertension, diabetes mellitus, obesity, lack of physical activity, and alcohol consumption.

The non-modifiable risk factors include advanced age, male sex, and genetics.

Symptoms

  • Intense, crushing type of substernal chest pain/ discomfort radiating to the jaws, left shoulder and arm. (Diabetic patients may not experience the chest pain due to the neuropathy)

  • Difficulty in breathing

  • Fear of impending death

  • Profuse sweating

  • Nausea

  • Warmness

  • Epigastric pain

Pathophysiology

An acute occlusion of one of the coronary arteries for a period of 20 to 40 minutes leads to acute myocardial infarction. The occlusion may be due to a thrombosis or the rupture of the atherosclerotic plaque. This causes myocardial ischemia leading to sarcolemmal disruption and myocardial relaxation. With a series of ultra-structural changes, coagulative necrosis of the myocardium takes place. The necrosis spreads to the sub-endocardium and sub-epicardium. The course of action is prolonged due to the increased collateral supply of epicardium.

Depending on the site of infarction, the cardiac function is compromised.

If timely reperfusion is implemented, the myocardium heals by scarring. The compensation including cardiac remodeling, hypertrophy etc. takes place.

Investigations and Evaluation

12 lead ECG showing the following characteristics:

  • ST segment elevation in 2 continuous leads

  • ST segment depression along with T wave changes like hyperacute T wave amplitude, prominent symmetrical T waves

  • Other myocardial ischemic findings like arrhythmias, AV conduction delay etc

Biomarkers include the following:

  • Raising or falling pattern of cardiac troponin (cTn) levels

  • Elevated creatine kinase MB isoform

  • Elevated levels of LDH after 24 hours

Clinical evidence of myocardial injury

  • Hypoxemia

  • Hypotension or shock

  • Anemia

  • Ventricular tachycardia

  • Heart failure

  • Kidney disease

Clinical classification of myocardial infarction

Type 1 myocardial Infarction:

MI due to rupture or erosion of atherosclerotic plaque.

It can further be classified based on the ECG findings as ST elevation myocardial infarction (STEMI) and Non ST elevation myocardial infarction (NSTEMI)

Criteria for diagnosis include

  • Symptoms of acute MI

  • ECG changes indicating ischemia

  • Imaging evidence of coronary thrombus by angiography

Type 2 myocardial infarction:

MI due to an imbalance in the myocardial oxygen demand and supply because of secondary disease.

Causes include GI bleed or tachyarrhythmia in presumed CAD patients, coronary vasospasm, coronary embolism, respiratory failure, severe anemia, Hypotension or shock etc.

Type 3 myocardial infarction:

Cardiac biomarkers in blood are fundamental for diagnosing type 3 MI.

Type 4a myocardial infarction:

MI is associated with percutaneous coronary intervention.

Type 4b myocardial infarction:

MI is associated with documented stent thrombosis.

Type 5 myocardial infarction:

MI is associated with coronary artery bypass grafting.

Classification according to the location of the infarct

Right ventricular myocardial infarction:

MI due to occlusion in the right coronary artery. The signs include increased RV pressure, tricuspid regurgitation and decreased cardiac output.

Inferoposterior myocardial infarction:

MI due to occlusion of the left circumflex artery leading to right ventricular dysfunction.

Anterior wall myocardial infarction:

MI due to the occlusion of the left coronary artery especially the anterior descending artery.

It has the worst prognosis.

Classification based on the extent of infarction

Transmural infarction:

MI involves the whole thickness of the myocardium.

Evidence of abnormal Q waves on ECG.

Laminar infarction:

Subendocardial infarct involving only the endocardium.

Evidence of ST - T abnormalities only.

Management

Acute management:

Reperfusion therapy:

It is indicated in all acute MI patients with less than 12 hours of symptoms.

  • Percutaneous coronary intervention (PCI)

It is passing a fine guidewire across a coronary stenosis under radiographic control and using it to position a balloon, which is then inflated to dilate the stenosis. It can be combined with a coronary stent.

Myocardial Infarction

  • Fibrinolysis like tenecteplase, alteplase, or reteplase.

  • Anticoagulants like unfractionated heparin, enoxaparin, and bivalirudin

Symptomatic relief:

  • Opioids for pain relief

  • Nitrates - Intravenous nitrates are more effective than sublingual nitrates

  • Beta-blockers - reduce myocardial oxygen consumption by decreasing heart rate, BP, and myocardial contractility.

  • Platelet inhibition - Aspirin, thromboxane A2 inhibitor, with a loading dose of 150 to 300mg and maintenance dose of 75 to 100 mg per day for the long term. Ticagrelor, an orally active P2Y12 inhibitor, can be used. Other P2Y12 inhibitors like clopidogrel, prasugrel can also be used.

Long-term management:

  • Lipid-lowering agents like Statins reduce LDL to stabilize the atherosclerotic plaque

  • Antithrombotic drugs like Aspirin, clopidogrel etc.

  • ACE inhibitors for patients with heart failure, hypertension etc

  • Antihypertensive drugs like beta blockers

Lifestyle modification:

  • Cessation of smoking, alcoholism

  • Diet and weight control

Complications

  • Reinfarction

  • Arrhythmias - supraventricular or Ventricular

  • AV block

  • Cardiac failure

  • Cardiac shock

  • Pericarditis

  • Embolism

  • Death due to Cardiac arrest




Reference:

  1. Davidson's Principles and Practice of Medicine

  2. PubMed Articles

  3. AHA website

  4. Google scholar


DotyCat - Teaching is Our Passion